Form 4 for PFE Pfizer

Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-11 · accession 0001225208-22-006909 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2022-05-12	2022-05-11	PFE	Dolsten Mikael	Pres R, D	S - Sale	$49.32	-63.9K	333.3K	-16%	-$3.15M
D	2022-05-12	2022-05-11	PFE	Dolsten Mikael	Pres R, D	I - Discretionary	$49.45	+15.2K	27.4K	+124%	+$750.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-11	S	D	2,358	$49.34	394,686	D	—	—
2	Common	Common Stock	2022-05-11	S	D	18,562	$49.32	365,357	D	—	—
3	Common	Common Stock	2022-05-11	S	D	7,876	$49.33	383,919	D	—	—
4	Common	Common Stock	2022-05-11	S	D	2,891	$49.35	391,795	D	—	—
5	Common	Common Stock	2022-05-11	S	D	200	$49.36	397,044	D	—	—
6	Common	Common Stock	2022-05-11	S	D	32,015	$49.31	333,342	D	—	—
7	Derivative	Phantom Stock Units SSP	2022-05-11	I	A	15,167	$49.45	27,380	D	— · — to —	15,167 Common Stock	(F2) This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. (F1) Each unit represents one phantom share of common stock. (F3) These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.